Lu AF35700
17303A
Phase 3 small_molecule terminated
Quick answer
Lu AF35700 for Treatment-resistant Schizophrenia is a Phase 3 program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- H. Lundbeck A/S
- Indication
- Treatment-resistant Schizophrenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated